TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Orion Pharma AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,031,607
|
928,999
|
787,123 |
| Financial expenses |
31
|
9
|
2 |
| Earnings before taxes |
46,944
|
40,217
|
33,147 |
| EBITDA |
44,257
|
38,586
|
32,804 |
| Total assets |
262,294
|
217,721
|
267,018 |
| Current assets |
258,938
|
214,347
|
263,653 |
| Current liabilities |
83,630
|
40,829
|
116,735 |
| Equity capital |
175,188
|
173,761
|
147,430 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
51
|
49
|
48 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
66.8%
|
79.8%
|
55.2% |
| Turnover per employee |
20,228
|
18,959
|
16,398 |
| Profit as a percentage of turnover |
4.6%
|
4.3%
|
4.2% |
| Return on assets (ROA) |
17.9%
|
18.5%
|
12.4% |
| Current ratio |
309.6%
|
525.0%
|
225.9% |
| Return on equity (ROE) |
26.8%
|
23.1%
|
22.5% |
| Change turnover |
85,858
|
86,024
|
22,468 |
| Change turnover % |
9%
|
10%
|
3% |
| Chg. No. of employees |
2
|
1
|
0 |
| Chg. No. of employees % |
4%
|
2%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.